Mueller V, Wardley A, Paplomata E, Hamilton E, et al. Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial). Eur J Cancer 2021;153:223-233.
PMID: 34214937